One-year remission of therapy-resistant SLE after a single course with the bispecific CD3: BCMA antibody teclistamab, but induction of a non-infectious Crohn's-like inflammatory bowel disease
- PMID: 40450406
- DOI: 10.1016/j.ard.2025.05.007
One-year remission of therapy-resistant SLE after a single course with the bispecific CD3: BCMA antibody teclistamab, but induction of a non-infectious Crohn's-like inflammatory bowel disease
Publication types
LinkOut - more resources
Full Text Sources
Research Materials